These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3135338)

  • 1. Melanin monomers within coated vesicles and premelanosomes in melanin synthesizing cells.
    Hatta S; Mishima Y; Ichihashi M; Ito S
    J Invest Dermatol; 1988 Aug; 91(2):181-4. PubMed ID: 3135338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory factors for polymerization of melanin monomers within coated vesicles and premelanosomes in melanoma cells.
    Wilczek A; Mishima Y
    Melanoma Res; 1993 Aug; 3(4):255-62. PubMed ID: 8219758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
    Mishima Y
    Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis.
    Wilczek A; Mishima Y
    Pigment Cell Res; 1995 Apr; 8(2):105-12. PubMed ID: 7659677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanogenic regulatory factors in coated vesicles from melanoma cells.
    Chakraborty AK; Mishima Y; Inazu M; Hatta S; Ichihashi M
    J Invest Dermatol; 1989 Nov; 93(5):616-20. PubMed ID: 2571641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities.
    Kameyama K; Sakai C; Kuge S; Nishiyama S; Tomita Y; Ito S; Wakamatsu K; Hearing VJ
    Pigment Cell Res; 1995 Apr; 8(2):97-104. PubMed ID: 7659683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of melanogenesis intermediates.
    Pavel S
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):162S-165S. PubMed ID: 8433003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of carbohydrate properties essential for melanogenesis in tyrosinases of cultured malignant melanoma cells by differential carbohydrate processing inhibition.
    Imokawa G
    J Invest Dermatol; 1990 Jul; 95(1):39-49. PubMed ID: 2114451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of mixed melanogenesis in tyrosinase cDNA-transfected human amelanotic melanoma cells.
    Ando O; Mishima Y; Hanada S; Suemoto Y; Atobe J; Kurimoto M
    J Invest Dermatol; 1993 Dec; 101(6):864-70. PubMed ID: 8245515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis.
    Menon IA; Haberman HF
    Acta Derm Venereol; 1978; 58(1):9-11. PubMed ID: 75646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRP-1 expression correlates with eumelanogenesis in human pigment cells in culture.
    del Marmol V; Ito S; Jackson I; Vachtenheim J; Berr P; Ghanem G; Morandini R; Wakamatsu K; Huez G
    FEBS Lett; 1993 Aug; 327(3):307-10. PubMed ID: 8348959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
    Aroca P; Solano F; Salinas C; García-Borrón JC; Lozano JA
    Eur J Biochem; 1992 Aug; 208(1):155-63. PubMed ID: 1511683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From tyrosine to melanin: Signaling pathways and factors regulating melanogenesis.
    Rzepka Z; Buszman E; Beberok A; Wrześniok D
    Postepy Hig Med Dosw (Online); 2016 Jun; 70(0):695-708. PubMed ID: 27356601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pmel 17/silver locus protein.
    Chakraborty AK; Platt JT; Kim KK; Kwon BS; Bennett DC; Pawelek JM
    Eur J Biochem; 1996 Feb; 236(1):180-8. PubMed ID: 8617263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-melanosomal regulatory factors in melanogenesis.
    Shibata T; Prota G; Mishima Y
    J Invest Dermatol; 1993 Mar; 100(3):274S-280S. PubMed ID: 8440903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione.
    Imokawa G
    J Invest Dermatol; 1989 Jul; 93(1):100-7. PubMed ID: 2501395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in subcellular distribution of catechol-O-methyltransferase and tyrosinase in malignant melanoma.
    Shibata T; Pavel S; Smit NP; Mishima Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):222S-225S. PubMed ID: 8433011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation.
    Jung H; Chung H; Chang SE; Choi S; Han IO; Kang DH; Oh ES
    Pigment Cell Melanoma Res; 2014 May; 27(3):387-97. PubMed ID: 24472179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chymotrypsin activation of melanosome tyrosinase in hamster melanotic melanoma.
    Blagoeva PM; Pandov HI; Stoichkova NI
    J Cancer Res Clin Oncol; 1979 Oct; 95(2):139-45. PubMed ID: 118173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of melanization within hair bulb melanocytes in chinchilla mutant by melanogenic stimulants.
    Imokawa G; Yada Y; Hori Y
    J Invest Dermatol; 1988 Aug; 91(2):106-13. PubMed ID: 2840469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.